Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jan 03, 2025 | Jan 07, 2025 | Dube Michael P VP Chief Accounting Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $12.18 | $16,711 | -2.92% |
Oct 02, 2024 | Oct 04, 2024 | Dube Michael P VP Chief Accounting Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $19.01 | $38,248 | -4.10% |